Clinical Profile of Patients of Retinal Vasculitis Attending OphthalmologyOPD of DMCH, Laheriasarai, Bihar

Background: Retinal vasculitis is an inflammatory condition of retinal vessels that can lead to vision loss. Itsetiology varies regionally, and data from Bihar are limited.Aim: To characterize the clinical presentation, underlying causes, treatment modalities, and visual outcomes ofretinal vasculitis at a tertiary centre in Bihar.Methods: In this retrospective case series, 75 patients (112 eyes) with fundus‐proven retinal vasculitis wereidentified from Jan 2021 to Dec 2021. Data on demographics, laterality, etiologic workup (infectious vs.noninfectious), presenting symptoms, ocular findings (vascular sheathing, hemorrhages, macular edema),treatment (corticosteroids, immunosuppressants, antivirals), and best‐corrected visual acuity (BCVA) atpresentation and 6-month follow-up were collected and analyzed.Results: Mean age was 34.6 ± 12.4 years; 60% were male. Bilateral involvement occurred in 49% of cases.Etiology was noninfectious in 68% (idiopathic 42%, systemic autoimmune 26%) and infectious in 32%(tuberculosis 18%, syphilis 8%, viral 6%). Common signs included perivascular sheathing (85%), retinalhemorrhages (62%), and macular edema (54%). Initial BCVA ≤ 20/60 was noted in 58% of eyes. Treatment withsystemic corticosteroids alone (45%) or combined with immunosuppressants (23%) led to stabilization orimprovement (≥2 lines) in 72% of eyes at 6 months; 38% required adjunctive antitubercular or antiviral therapy.Final BCVA ≥ 20/40 was achieved in 64% of eyes.Conclusion: At our centre, retinal vasculitis primarily affected young adults, with idiopathic and tubercularetiologies predominating. Early diagnosis and tailored therapy resulted in favorable visual outcomes in mostpatients.